4//SEC Filing
Stout Jay S 4
Accession 0001764013-25-000019
CIK 0001764013other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:23 PM ET
Size
5.3 KB
Accession
0001764013-25-000019
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Stout Jay S
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-01-22$23.59/sh−2,195$51,780→ 139,991 total
Footnotes (1)
- [F1]On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on January 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001702969
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:23 PM ET
- Size
- 5.3 KB